Advertisement

Mean Arterial Pressure: Therapeutic Goals and Pharmacologic Support

  • David S. Shapiro
    Correspondence
    Corresponding author. Saint Francis Medical Group, 1000 Asylum Avenue, Suite 4320, Hartford, CT 06105.
    Affiliations
    Department of Surgery, University of Connecticut School of Medicine, Farmington, CT, USA

    Saint Francis Hospital and Medical Center, Department of Surgery, 114 Woodland Street, Hartford, CT 06106, USA

    Saint Francis Medical Group, 1000 Asylum Avenue, Suite 4320, Hartford, CT 06105, USA
    Search for articles by this author
  • Laurie A. Loiacono
    Affiliations
    Department of Surgery, University of Connecticut School of Medicine, Farmington, CT, USA

    Saint Francis Hospital and Medical Center, Department of Surgery, 114 Woodland Street, Hartford, CT 06106, USA
    Search for articles by this author

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rivers E.
        • Nguyen B.
        • Havstad S.
        • et al.
        Early goal-directed therapy in the treatment of severe sepsis and septic shock.
        N Engl J Med. 2001; 345: 1368-1377
        • Dellinger R.P.
        • Levy M.M.
        • Carlet J.M.
        • et al.
        Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock.
        Intensive Care Med. 2008; 34: 17-60
        • Varpula M.
        • Tallgren M.
        • Saukkonen K.
        • et al.
        Hemodynamic variables related to outcome in septic shock.
        Intensive Care Med. 2005; 31: 1066-1071
        • Hayes M.A.
        • Timins A.C.
        • Yau E.H.
        • et al.
        Elevation of systemic oxygen delivery in the treatment of critically ill patients.
        N Engl J Med. 1994; 330: 1717-1722
        • Gattinoni L.
        • Brazzi L.
        • Pelosi P.
        • et al.
        A trial of goal-oriented hemodynamic therapy in critically ill patients: svO2 Collaborative Group.
        N Engl J Med. 1995; 333: 1025-1032
        • Hollenberg S.M.
        • Ahrens T.S.
        • Annane D.
        • et al.
        Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update.
        Crit Care Med. 2004; 32: 1928-1948
        • LeDoux D.
        • Astiz M.E.
        • Carpati C.M.
        • et al.
        Effects of perfusion pressure on tissue perfusion in septic shock.
        Crit Care med. 2000; 28: 2729-2732
        • DiGiantomasso D.
        • May C.N.
        • Bellomo R.
        Vital organ blood flow during sepsis.
        Chest. 2003; 124: 1053-1059
        • Schlame M.
        • Blanck T.J.J.
        Cardiovascular system.
        in: Gabrielli A. Layon A.J. Mihae Y. Civetta Taylor and Kirby's critical care. 4th edition. Lippincott Williams & Wilkins, Philadelphia (PA)2009: 693-695
        • Darovic G.O.
        Cardiovascular anatomy and physiology.
        in: Darovi G.O. Hemodynamic monitoring: invasive and noninvasive clinical application. 2nd edition. WB Saunders, Philadelphia (PA)2002: 103-105
        • Magner L.N.
        A history of the life sciences.
        Marcel Dekker, Inc, Philadelphia (PA)2002 (p. 223–5)
        • Marino P.L.
        The ICU book.
        Lippincott Williams & Wilkins, Philadelphia (PA)2007 (p. 151–4)
        • Bur A.
        • Hirschl M.
        • Vleck M.
        • et al.
        Factors influencing the accuracy of oscillometric blood pressure measurements in critically ill patients.
        Crit Care Med. 2003; 31: 793-799
        • Davis R.F.
        Clinical comparison of automated auscultatory and oscillometric and catheter-transducer measurements of arterial pressure.
        J Clin Monit. 1985; 1: 114-119
        • Shlyakhto E.
        • Conrady A.
        Korotkoff sounds: what do we know about its discovery?.
        J Hypertens. 2005; 23: 3-4
        • Leone M.
        • Martin C.
        Vasopressor use in septic shock: an update.
        Curr Opin Anesthesiol. 2008; 21: 141-147
        • Bourgoin A.
        • Leone M.
        • Delmas A.
        • et al.
        Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function.
        Crit Care Med. 2005; 33: 780-786
        • Holmes C.L.
        • Walley K.R.
        Vasoactive drugs for vasodilatory shock in ICU.
        Curr Opin Crit Care. 2009; 15: 398-402
        • Beale R.J.
        • Hollenberg S.M.
        • Vincent J.L.
        • et al.
        Vasopressor and inotropic support in septic shock: an evidence based review.
        Crit Care Med. 2004; 32: S455-S465
        • Müllner M.
        • Urbanek B.
        • Havel C.
        • et al.
        Vasopressors for shock.
        Cochrane Database Syst Rev. 2004; (CD003709)
        • Levy B.
        • Bollaert P.E.
        • Charpentier C.
        • et al.
        Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
        Intensive Care Med. 1997; 23: 282-287
        • Wakatsuki T.
        • Nakaya Y.
        • Inoue I.
        Vasopressin modulates K+ channel activities of cultured smooth muscle cells from porcine coronary artery.
        Am J Physiol. 1992; 263: H491-H496
        • Flancbaum L.
        • Dick M.
        • Dasta J.F.
        • et al.
        A dose-response study of phenyleprhine in critically ill, septic surgical patients.
        Eur J Clin Pharmacol. 1997; 51: 461-465
        • Martin C.
        • Papazian L.
        • Perrin G.
        • et al.
        Norepinephrine or dopamine for the treatment of hyperdynamic septic shock.
        Chest. 1993; 103: 1826-1831
        • Jhanji S.
        • Stirling S.
        • Patel N.
        • et al.
        The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock.
        Crit Care Med. 2009; 37: 1961-1966
        • Holmes C.L.
        • Patel B.M.
        • Russell J.A.
        • et al.
        Physiology of vasopressin relevant to management of septic shock.
        Chest. 2001; 120: 989-1002
        • Barrett B.J.
        • Parfrey P.S.
        Clinical practice: preventing nephropathy induced by contrast medium.
        N Engl J Med. 2006; 34: 379-386